Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Technical advance: actin CytoFRET, a novel FRET flow cytometry method for detection of actin dynamics in resting and activated T cell.

Auteurs Larbret F, Dubois N, Brau F, Guillemot E, Mahiddine K, Tartare-Deckert S, Verhasselt V, Deckert M

Journal of leukocyte biology Sep 2013

Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.

Auteurs Garcia S, Dirat B, Tognacci T, Rochet N, Mouska X, Bonnafous S, Patouraux S, Tran A, Gual P, Le Marchand-Brustel Y, Gennero I, Gouze E

Science translational medicine Sep 2013

The emerging role of connexin 43 in testis pathogenesis.

Auteurs Chevallier D, Carette D, Gilleron J, Segretain D, Pointis G

Current molecular medicine Sep 2013

The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.

Auteurs Rosilio C, Lounnas N, Nebout M, Imbert V, Hagenbeek T, Spits H, Asnafi V, Pontier-Bres R, Reverso J, Michiels JF, Sahra IB, Bost F, Peyron JF

Cancer letters Aug 2013

GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death.

Auteurs Jacquin MA, Chiche J, Zunino B, Bénéteau M, Meynet O, Pradelli LA, Marchetti S, Cornille A, Carles M, Ricci JE

Cell death and differentiation Aug 2013

Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.

Auteurs Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC

Pigment cell & melanoma research Août 2013

Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.

Auteurs Bertero T, Bourget-Ponzio I, Puissant A, Loubat A, Mari B, Meneguzzi G, Auberger P, Barbry P, Ponzio G, Rezzonico R

Cell cycle (Georgetown, Tex.) Jul 2013

Nepheliosyne B, a new polyacetylenic acid from the new caledonian marine sponge Niphates sp.

Auteurs Legrave N, Hamrouni-Buonomo S, Dufies M, Guérineau V, Vacelet J, Auberger P, Amade P, Mehiri M

Marine drugs Jun 2013

Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines.

Auteurs Dufies M, Cassuto O, Jacquel A, Robert G, Auberger P

Cell cycle (Georgetown, Tex.) Jun 2013

Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.

Auteurs Lounnas N, Rosilio C, Nebout M, Mary D, Griessinger E, Neffati Z, Chiche J, Spits H, Hagenbeek TJ, Asnafi V, Poulsen SA, Supuran CT, Peyron JF, Imbert V

Cancer letters Jun 2013